Journal Summary - Discover more summaries and articles from M3 India

Oncology

Choose Topic

Subcutaneous trastuzumab (herceptin) vs intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit

European Journal of Obstetrics & Gynecology and Reproductive Biology | Dec 12, 2017 Pharmacology/Therapy General Oncology Breast

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

OncoTargets and Therapy | Dec 12, 2017 General Oncology Renal/Urologic

Seizure rates in enzalutamide-treated men with metastatic castration-resistant prostate cancer and risk of seizure: The UPWARD Study

JAMA Oncology | Dec 12, 2017 Pharmacology/Therapy General Oncology Renal/Urologic

Contemporary hormonal contraception and the risk of breast cancer

New England Journal of Medicine | Dec 11, 2017 Breast General Oncology

Outpatient pain medication use: An electronic daily diary study in metastatic breast cancer

Journal of Pain and Symptom Management | Dec 11, 2017 Breast General Oncology Pain Management/Palliative Care

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Cancer Immunology, Immunotherapy | Dec 11, 2017 Pharmacology/Therapy General Oncology Leukemia/Lymphoma

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Cancer | Dec 10, 2017 General Oncology Colorectal Cancer/Polyps

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

World Journal of Urology | Dec 10, 2017 General Oncology Renal/Urologic

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients

Journal of Gastrointestinal Oncology | Dec 10, 2017 Hepatobiliary/Pancreas General Oncology Pharmacology/Therapy

Survival in patients with primary Dermatofibrosarcoma Protuberans: National Cancer Data Base analysis

Journal of the American Academy of Dermatology | Dec 09, 2017 Dermatologic Oncology General Oncology

« Prev 1 … 1120 1121 1122 1123 1124 … 1255 Next »

Subcutaneous trastuzumab (herceptin) vs intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Seizure rates in enzalutamide-treated men with metastatic castration-resistant prostate cancer and risk of seizure: The UPWARD Study

Contemporary hormonal contraception and the risk of breast cancer

Outpatient pain medication use: An electronic daily diary study in metastatic breast cancer

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients

Survival in patients with primary Dermatofibrosarcoma Protuberans: National Cancer Data Base analysis

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Acute Ischaemic Stroke: Recent Therapies and Guidelines MCQ Challenge

The Impact of Gut Health on Overall Wellbeing: Integrating Conventional and Natural Approaches

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Managing Chronic Kidney Disease

Subcutaneous trastuzumab (herceptin) vs intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Seizure rates in enzalutamide-treated men with metastatic castration-resistant prostate cancer and risk of seizure: The UPWARD Study

Contemporary hormonal contraception and the risk of breast cancer

Outpatient pain medication use: An electronic daily diary study in metastatic breast cancer

Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells

Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients

Survival in patients with primary Dermatofibrosarcoma Protuberans: National Cancer Data Base analysis

The Y Chromosome is Dying: What Does it Means for Men’s Health?

Acute Ischaemic Stroke: Recent Therapies and Guidelines MCQ Challenge

The Impact of Gut Health on Overall Wellbeing: Integrating Conventional and Natural Approaches

Top 5 Strategies for Improving Your Patients' Asthma Control, Per the Experts

Managing Chronic Kidney Disease

Select Specialty

Select Topic